Navigation Links
Failure Rate of DePuy ASR XL Hip Implant Rising
Date:3/31/2011

FORT WORTH, Texas, March 31, 2011 /PRNewswire/ -- Recent information presented at the British Hip Society Annual Conference held from March 2 -4, 2011 indicates a rise in the failure rate of the DePuy ASR XL Acetabular Hip Replacement System which was manufactured and marketed by DePuy Orthopaedics, Inc., a subsidiary of Johnson & Johnson.  The British Orthopaedic Association has released a summary of the results of the study presented, stating that the early failure rates "range from 21% revision rate at 4 years (potentially rising to 35% if all currently known painful implants progress to revision) to 49% at 6 years for the ASR XL device."  This summary was included in an article published on the British Orthopaedic Association's website entitled "Large Diameter Metal on Metal Bearing Total Hip Replacements."

"The DePuy ASR XL Hip Replacement Systems were first sold by DePuy and Johnson & Johnson in the UK and other countries in 2003. The ASR XL was sold in the United States beginning in 2005. It now appears that patients who received these implants are experiencing failures at a staggering rate. The device was recalled by DePuy Orthopaedics, Inc. on August 24, 2010. Sales of a medical product with a failure rate of 49% at six years is unconscionable. Profits over patient safety is unacceptable," said attorney John David Hart of the Law Offices of John David Hart who represents many individuals in the United States who have been injured as a result of this defective hip replacement system.

DePuy identified reasons for the failure of the hip replacement system as component loosening, component malalignment, infection, fracture of the bone, dislocation, metal sensitivity and pain. Additional complications from the DePuy ASR XL Acetabular Hip Replacement System may include increased metal ion levels in the blood, bone staining, necrosis, swelling, nerve damage, tissue damage and/or muscle damage.

The Law Offices of John David Hart is a group of experienced and dedicated legal professionals working to protect the rights of people wronged by the acts of others.  Across the country, the firm represents individuals in cases of catastrophic personal injury, wrongful death, dangerous drugs and medical products, automobile and truck accidents and oil and gas litigation.  For more information, please contact John David Hart at 800.961.4278 or johnhart@hartlaw.com or visit www.hiprecallinfo.com.


'/>"/>
SOURCE The Law Offices of John David Hart
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Qualitest Receives FDA Approval for Toresmide Tablets (Generic Demadex®) 5 mg, 10 mg, 20 mg, 100 mg, for the Treatment of Edema Associated with Congestive Heart Failure, Renal Disease, or Hepatic Disease
2. Pervasis Receives Orphan Drug Designation in Europe for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
3. Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure
4. Nile Therapeutics to Collaborate with Medtronic on Clinical Development of Cenderitide for Heart Failure and Renal Disease
5. Success Factors and Failure Points in Biopharmaceutical Product Launches
6. Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
7. FDA Issues Complete Response Letter Regarding Acetadote® Supplemental New Drug Application for Acute Liver Failure
8. Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients
9. New White Paper: Having a Solid Package Validation Program Can Prevent Failure of Combination Products
10. NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events
11. Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... and PUNE, India , January ... by Allied Market Research, titled, "Vital Signs Monitoring Devices Market ... Forecast, 2014-2022", projects that the global vital signs monitoring devices ... expected to reach $5,491 million by 2022, growing at a ... America was the leading regional market in global ...
(Date:1/16/2017)... Oregon and PUNE, India , January 16, 2017 ... Research, titled, "Antioxidants Market by Type - Global Opportunity Analysis and Industry Forecast, ... is expected to reach $4,531 million by 2022, registering a CAGR of 6.42% ... for more than one-third share of the global volume in 2015. ... ...
(Date:1/16/2017)... 16, 2017  Dovetail Genomics today announced the commercial ... service, which yields chromosome-scale genome assemblies. The service is ... workshop on Jan. 17 at the Plant & Animal ... . "We are thrilled to be ... our Dovetail Hi-C offering," said Todd Dickinson , ...
Breaking Medicine Technology:
(Date:1/16/2017)... GA (PRWEB) , ... January 16, 2017 , ... ... to announce their recent partnership with an innovator in the wheelchair accessibility industry, ... to motivate their dealer salespeople to sell wheelchair accessible vehicles. With this new ...
(Date:1/16/2017)... ... ... One thing common to all types of cancer is that it’s a ... money spent screening for and treating cancer in the United States is estimated to ... than in any other country that has an advanced healthcare system, sometimes spending as ...
(Date:1/15/2017)... ... January 15, 2017 , ... Going above and ... that strives to better communities around the world by offering the Gensuite team ... the opportunity for team members to become involved in a cause that is ...
(Date:1/15/2017)... ... 14, 2017 , ... Wondering where to go this Valentine's Day? Well, there ... for a romantic, lobster feast in the comfort of your own home. Lobster Gram ... dinners will be featured until February 15th, 2017. , Romantic Dinner one is ...
(Date:1/14/2017)... ... January 14, 2017 , ... AgileMinder develops innovative products and services ... Scale is now available on Apple as a fun, free emoji sticker pack for ... one of the ten color coded values on The Emoji Scale. , On ...
Breaking Medicine News(10 mins):